Schonfeld Strategic Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-655,885
| Closed | -$1.12M | – | 2148 |
|
|
2024
Q3 | $1.12M | Buy |
+655,885
| New | +$1.12M | 0.01% | 998 |
|
|
2024
Q2 | – | Sell |
-268,245
| Closed | -$1.01M | – | 2256 |
|
|
2024
Q1 | $1.01M | Buy |
268,245
+116,869
| +77% | +$438K | 0.01% | 1060 |
|
|
2023
Q4 | $1.48M | Sell |
151,376
-129,124
| -46% | -$1.27M | 0.01% | 838 |
|
|
2023
Q3 | $2.34M | Sell |
280,500
-96,800
| -26% | -$808K | 0.02% | 672 |
|
|
2023
Q2 | $5.02M | Buy |
377,300
+165,962
| +79% | +$2.21M | 0.04% | 485 |
|
|
2023
Q1 | $2.45M | Buy |
211,338
+156,638
| +286% | +$1.81M | 0.02% | 633 |
|
|
2022
Q4 | $447K | Sell |
54,700
-32,425
| -37% | -$265K | ﹤0.01% | 1573 |
|
|
2022
Q3 | $505K | Buy |
+87,125
| New | +$505K | ﹤0.01% | 1705 |
|
|
2020
Q1 | – | Sell |
-280,960
| Closed | -$1.45M | – | 1410 |
|
|
2019
Q4 | $1.45M | Buy |
+280,960
| New | +$1.45M | 0.04% | 405 |
|
|
2017
Q1 | – | Sell |
-10,000
| Closed | -$38K | – | 696 |
|
|
2016
Q4 | $38K | Buy |
+10,000
| New | +$38K | ﹤0.01% | 527 |
|
|
2016
Q3 | – | Sell |
-41,859
| Closed | -$295K | – | 504 |
|
|
2016
Q2 | $295K | Buy |
41,859
+31,859
| +319% | +$225K | 0.07% | 318 |
|
|
2016
Q1 | $85K | Buy |
+10,000
| New | +$85K | 0.03% | 289 |
|